Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn(Newcastle University), Anne‐Marie Gerdes(Rigshospitalet), Finlay Macrae(The Royal Melbourne Hospital), Jukka‐Pekka Mecklin(University of Eastern Finland), Gabriela Möslein(St. Josefs Hospital), Sylviane Olschwang(Institut Paoli-Calmettes), Diana Eccles(Princess Anne Hospital), D. Gareth Evans(St Mary's Hospital), Eamonn R. Maher(University of Birmingham), Lucio Bertario(Fondazione IRCCS Istituto Nazionale dei Tumori), Marie-Luise Bisgaard(University of Copenhagen), Malcolm G. Dunlop(Western General Hospital), Judy Ho(Queen Mary Hospital), Shirley V. Hodgson(St George's Hospital), Annika Lindblom(Karolinska Institutet), Jan Lubiński(International Hereditary Cancer Center), Patrick J. Morrison(Queen's University Belfast), Victoria Murday, Raj Ramesar(University of Cape Town), Lucy Side(Churchill Hospital), Rodney J. Scott(John Hunter Hospital), Huw Thomas(St Mark's Hospital), Hans F. A. Vasen(Leiden University), G Barker(Newcastle University), Gillian Crawford(Princess Anne Hospital), Faye Elliott(University of Leeds), Mohammad Movahedi(University of Leeds), Kirsi Pylvänäinen(University of Eastern Finland), Juul Wijnen(Leiden University Medical Center), Riccardo Fodde(Erasmus University Rotterdam), Henry T. Lynch(CHI Health Creighton University Medical Center - Bergan Mercy), John C. Mathers(Newcastle University), D. Timothy Bishop(University of Leeds)
Cited by 949Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis